TABLE 2.
Diagnostic test and diagnostic criterion | % of samples fulfilling criterion at no. of wks after infection (no. of serum specimens examined)
|
||||||||
---|---|---|---|---|---|---|---|---|---|
1 (14) | 2 (13) | 3 (6) | 4 (10) | 5 (9) | 6–10 (22) | 11–15 (13) | 16–20 (10) | 21–52 (29) | |
Dye test | |||||||||
≥3 IU/ml | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
≥300 IU/ml | 0 | 0 | 0 | 40 | 56 | 68 | 62 | 70 | 31 |
Platelia Toxo-IgG | |||||||||
≥6 IU/ml | 0 | 100 | 100 | 82 | 89 | 100 | 100 | 100 | 97 |
Toxo-Screen DA IgG | |||||||||
Titer, ≥40 | 50 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Platelia Toxo-IgM | |||||||||
≥100% | 93 | 100 | 100 | 100 | 100 | 91 | 92 | 100 | 76 |
Toxo-ISAGA IgM | |||||||||
Index, ≥6 | 100 | 100 | 100 | 100 | 89 | 100 | 85 | 90 | 79 |
Index, ≥9 | 93 | 90 | 100 | 100 | 89 | 100 | 77 | 90 | 76 |
Platelia Toxo-IgA | |||||||||
≥100% | 21 | 82a | 67 | 50 | 75b | 77 | 62 | 60 | 45 |
Eleven sera were examined.
Seven sera were examined.